HK:6185 Stock Latest News
Company AnnouncementsCanSino Biologics Posts Revenue Growth but Core Profit and Cash Flow Under Strain5d ago
Company AnnouncementsCanSino Biologics Schedules Board Meeting to Approve Third-Quarter Results2w ago
Company AnnouncementsCanSino Biologics Grants Reserved Restricted Shares Under 2025 Incentive Scheme1M ago
Company AnnouncementsCanSino Biologics Publishes Unaudited Interim Results for First Half of 20262M ago
Company AnnouncementsCanSino Biologics Advances mRNA Platform and Forms Cancer Vaccine Alliance2M ago
Company AnnouncementsCanSino Wins NMPA Approval for New Tetanus Vaccine, Boosting Adult Vaccine Portfolio2M agoCompany AnnouncementsCanSino’s Td5cp Booster Wins Priority Review After NDA Acceptance in China2M ago
Company AnnouncementsCanSino Biologics Sets Board Meeting to Approve Interim Results and Consider Dividend2M ago
Company AnnouncementsCanSino Wins NMPA Nod to Expand Age Range for Menhycia Vaccine3M ago- Company AnnouncementsCanSino Wins Argentine Approval for Menhycia Vaccine as Global Push Accelerates4M ago
Company AnnouncementsCanSino Biologics Shareholders Approve All AGM Resolutions and Amend Articles4M ago- Company AnnouncementsCanSino Launches First-in-Class 24-Valent Pneumococcal Vaccine Trial5M ago
Company AnnouncementsCanSino Biologics Sets 2025 AGM With Broad Capital and Governance Mandates on Agenda5M ago
- Company AnnouncementsCanSino Biologics Tightens Governance With Proposed Articles and Board Rule Changes6M ago
- Company AnnouncementsCanSino Biologics Sets April 28 Board Meeting to Approve Q1 2026 Results6M ago
- Company AnnouncementsCanSino Wins China Approval for First DTcP Components Infant Vaccine6M ago
Company AnnouncementsCanSino Biologics Publishes Audited 2025 Annual Results and Readies Full Report7M ago
Company AnnouncementsCanSino Biologics Sets March 30 Board Meeting to Approve 2025 Results7M ago